Industry Growth Insights published a new data on “Preventable Vaccines Market”. The research report is titled “Preventable Vaccines Market research by Types (Adult Preventable Vaccines, Pediatric Preventable Vaccines), By Applications (Bacterial Diseases, Virus Diseases), By Players/Companies GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche, AstraZeneca, Mitsubishi Tanabe Pharma, Lupin, Serum Institute of India, LG Life Sciences, S K Chemicals, Shenzhen Kangtai Biological Products, Sinovac Biotech, Janssen Pharmaceuticals, Crucell, Bavarian Nordic, Baxter, Bharat Biotech, Dynavax, Bausch Health, Protein Sciences, Panacea Biotec”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preventable Vaccines Market Research Report
By Type
Adult Preventable Vaccines, Pediatric Preventable Vaccines
By Application
Bacterial Diseases, Virus Diseases
By Companies
GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche, AstraZeneca, Mitsubishi Tanabe Pharma, Lupin, Serum Institute of India, LG Life Sciences, S K Chemicals, Shenzhen Kangtai Biological Products, Sinovac Biotech, Janssen Pharmaceuticals, Crucell, Bavarian Nordic, Baxter, Bharat Biotech, Dynavax, Bausch Health, Protein Sciences, Panacea Biotec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Preventable Vaccines Market Report Segments:
The global Preventable Vaccines market is segmented on the basis of:
Types
Adult Preventable Vaccines, Pediatric Preventable Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bacterial Diseases, Virus Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Novartis
- Pfizer
- Sanofi
- Takeda Pharmaceutical
- Abbott
- Roche
- AstraZeneca
- Mitsubishi Tanabe Pharma
- Lupin
- Serum Institute of India
- LG Life Sciences
- S K Chemicals
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Janssen Pharmaceuticals
- Crucell
- Bavarian Nordic
- Baxter
- Bharat Biotech
- Dynavax
- Bausch Health
- Protein Sciences
- Panacea Biotec
Highlights of The Preventable Vaccines Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Adult Preventable Vaccines
- Pediatric Preventable Vaccines
- By Application:
- Bacterial Diseases
- Virus Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preventable Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preventable vaccines are those that can be prevented by using safe practices. These vaccines include diseases such as measles, mumps, and rubella (MMR), which can cause serious health problems in children and adults.
Some of the major companies in the preventable vaccines market are GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche, AstraZeneca, Mitsubishi Tanabe Pharma, Lupin, Serum Institute of India, LG Life Sciences, S K Chemicals, Shenzhen Kangtai Biological Products, Sinovac Biotech, Janssen Pharmaceuticals, Crucell, Bavarian Nordic, Baxter, Bharat Biotech, Dynavax, Bausch Health, Protein Sciences, Panacea Biotec.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Preventable Vaccines Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Preventable Vaccines Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Preventable Vaccines Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Preventable Vaccines Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Preventable Vaccines Market Size & Forecast, 2018-2028
4.5.1 Preventable Vaccines Market Size and Y-o-Y Growth
4.5.2 Preventable Vaccines Market Absolute $ Opportunity
Chapter 5 Global Preventable Vaccines Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Preventable Vaccines Market Size Forecast by Type
5.2.1 Adult Preventable Vaccines
5.2.2 Pediatric Preventable Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Preventable Vaccines Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Preventable Vaccines Market Size Forecast by Applications
6.2.1 Bacterial Diseases
6.2.2 Virus Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Preventable Vaccines Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Preventable Vaccines Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Preventable Vaccines Analysis and Forecast
9.1 Introduction
9.2 North America Preventable Vaccines Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Preventable Vaccines Market Size Forecast by Type
9.6.1 Adult Preventable Vaccines
9.6.2 Pediatric Preventable Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Preventable Vaccines Market Size Forecast by Applications
9.10.1 Bacterial Diseases
9.10.2 Virus Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Preventable Vaccines Analysis and Forecast
10.1 Introduction
10.2 Europe Preventable Vaccines Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Preventable Vaccines Market Size Forecast by Type
10.6.1 Adult Preventable Vaccines
10.6.2 Pediatric Preventable Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Preventable Vaccines Market Size Forecast by Applications
10.10.1 Bacterial Diseases
10.10.2 Virus Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Preventable Vaccines Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Preventable Vaccines Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Preventable Vaccines Market Size Forecast by Type
11.6.1 Adult Preventable Vaccines
11.6.2 Pediatric Preventable Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Preventable Vaccines Market Size Forecast by Applications
11.10.1 Bacterial Diseases
11.10.2 Virus Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Preventable Vaccines Analysis and Forecast
12.1 Introduction
12.2 Latin America Preventable Vaccines Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Preventable Vaccines Market Size Forecast by Type
12.6.1 Adult Preventable Vaccines
12.6.2 Pediatric Preventable Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Preventable Vaccines Market Size Forecast by Applications
12.10.1 Bacterial Diseases
12.10.2 Virus Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Preventable Vaccines Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Preventable Vaccines Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Preventable Vaccines Market Size Forecast by Type
13.6.1 Adult Preventable Vaccines
13.6.2 Pediatric Preventable Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Preventable Vaccines Market Size Forecast by Applications
13.10.1 Bacterial Diseases
13.10.2 Virus Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Preventable Vaccines Market: Competitive Dashboard
14.2 Global Preventable Vaccines Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Novartis
14.3.4 Pfizer
14.3.5 Sanofi
14.3.6 Takeda Pharmaceutical
14.3.7 Abbott
14.3.8 Roche
14.3.9 AstraZeneca
14.3.10 Mitsubishi Tanabe Pharma
14.3.11 Lupin
14.3.12 Serum Institute of India
14.3.13 LG Life Sciences
14.3.14 S K Chemicals
14.3.15 Shenzhen Kangtai Biological Products
14.3.16 Sinovac Biotech
14.3.17 Janssen Pharmaceuticals
14.3.18 Crucell
14.3.19 Bavarian Nordic
14.3.20 Baxter
14.3.21 Bharat Biotech
14.3.22 Dynavax
14.3.23 Bausch Health
14.3.24 Protein Sciences
14.3.25 Panacea Biotec
